Radiation therapy inhibits osteoclastogenesis by destroying osteoclast precursors and down-regulating RANKL expression in pre-osteoblastic cells

被引：0
|
作者：
Allen, MJ [1 ]
Leone, KA [1 ]
Wang, Y [1 ]
Margulies, BS [1 ]
Damron, TA [1 ]
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1599 / 1599
页数：1
相关论文
共 50 条
  • [1] Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells
    Lee, Ji-Won
    Iwahashi, Ayumi
    Hasegawa, Shin-ichi
    Yonezawa, Takayuki
    Jeon, Won Bae
    Cha, Byung-Yoon
    Nagai, Kazuo
    Woo, Je-Tae
    JOURNAL OF NATURAL MEDICINES, 2012, 66 (01) : 8 - 16
  • [2] Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells
    Ji-Won Lee
    Ayumi Iwahashi
    Shin-ichi Hasegawa
    Takayuki Yonezawa
    Won Bae Jeon
    Byung-Yoon Cha
    Kazuo Nagai
    Je-Tae Woo
    Journal of Natural Medicines, 2012, 66 : 8 - 16
  • [3] Tenuigenin inhibits RANKL-induced osteoclastogenesis by down-regulating NF-κB activation and suppresses bone loss in vivo
    Yang, Shuo
    Li, Xianan
    Cheng, Liang
    Wu, Hongwei
    Zhang, Can
    Li, Kanghua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 466 (04) : 615 - 621
  • [4] Antitumor Agent Cabozantinib Decreases RANKL Expression in Osteoblastic Cells and Inhibits Osteoclastogenesis and PTHrP-Stimulated Bone Resorption
    Stern, Paula H.
    Alvares, Keith
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2014, 115 (11) : 2033 - 2038
  • [5] Blocking BRE expression in Leydig cells inhibits steroidogenesis by down-regulating 3β-hydroxysteroid dehydrogenase
    Miao, J
    Chan, KW
    Chen, GG
    Chun, SY
    Xia, NS
    Chan, JYH
    Panesar, NS
    JOURNAL OF ENDOCRINOLOGY, 2005, 185 (03) : 507 - 517
  • [6] PPAR GAMMA AGONIST ROSIGLITAZONE COULD INHIBIT RA-FLS INDUCED OSTEOCLASTOGENESIS BY DOWN-REGULATING RANKL EXPRESSION AND SUPPRESSION OF ERK PHOSPHORYLATION
    Wei, X. N.
    Dai, L.
    Zhu, L. J.
    Mo, Y. Q.
    Zheng, D. H.
    Zhang, B. Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 165 - 165
  • [7] Pregnane X receptor inhibits the transdifferentiation of hepatic stellate cells by down-regulating periostin expression
    Sato, Takumi
    Shizu, Ryota
    Baba, Ryonosuke
    Ooka, Akira
    Hosaka, Takuomi
    Kanno, Yuichiro
    Yoshinari, Kouichi
    BIOCHEMICAL JOURNAL, 2024, 481 (18) : 1173 - 1186
  • [8] VEGF/HGF Inhibitor Cabozantinib Decreases RANKL Expression in Osteoblastic Cells and Inhibits Osteoclastogenesis and PTHrP-Stimulated Bone Resorption.
    Stern, Paula
    Alvares, Keith
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S141 - S141
  • [9] Paclitaxel inhibits natural killer cell binding to target cells by down-regulating adhesion molecule expression
    Loubani, O
    Hoskin, DW
    ANTICANCER RESEARCH, 2005, 25 (2A) : 735 - 741
  • [10] Epigallocatechin-3-gallate Inhibits Osteoclastogenesis by Down-Regulating c-Fos Expression and Suppressing the Nuclear Factor-κB Signal
    Lee, Jong-Ho
    Jin, Hexiu
    Shim, Hye-Eun
    Kim, Ha-Neui
    Ha, Hyunil
    Lee, Zang Hee
    MOLECULAR PHARMACOLOGY, 2010, 77 (01) : 17 - 25
12345